Skeletal muscle mitochondria (SMM) (SMM)

Skeletal muscle mitochondria are specialized organelles responsible for generating the vast majority of adenosine triphosphate (ATP) required for muscle contraction through oxidative phosphorylation (StatPearls, 2023). They exist in two primary populations: subsarcolemmal mitochondria, located beneath the cell membrane, and intermyofibrillar mitochondria, situated between the contractile filaments (Hood, 2001). Beyond energy production, they play critical roles in regulating cellular calcium levels, signaling through reactive oxygen species (ROS), and initiating apoptotic pathways (Spinelli & Haigis, 2018). These organelles are highly dynamic, undergoing constant fusion and fission to maintain quality and respond to metabolic demands (Giacomello et al., 2020). Dysfunction in skeletal muscle mitochondria is a hallmark of various metabolic and neuromuscular diseases, including type 2 diabetes, sarcopenia, and primary mitochondrial myopathies (Russell et al., 2014). Pharmacological interventions often aim to enhance mitochondrial biogenesis via PGC-1alpha pathways or improve respiratory efficiency using small molecules like elamipretide (Daussin et al., 2021). Conversely, many drugs, such as certain statins and antibiotics, can cause unintended mitochondrial toxicity, leading to adverse muscle effects (Vial et al., 2019). Monitoring mitochondrial health in skeletal muscle is essential for assessing metabolic fitness and the safety profile of systemic therapies (Porter et al., 2015).

Other names

Muscle mitochondriaMyofibrillar mitochondriaSubsarcolemmal mitochondriaIntermyofibrillar mitochondria

Modulation of the electron transport chain, stabilization of the inner mitochondrial membrane through cardiolipin binding, and induction of mitochondrial biogenesis via transcriptional coactivators (Vial et al., 2019; Daussin et al., 2021).